HeartX Cardiovascular Accelerator Seeks Innovative Early-Stage Companies for 2025 Program

BENTONVILLE, Ark., Feb. 3, 2025 /PRNewswire/ — HealthTech Arkansas and MedAxiom have launched year four of HeartX, a cardiovascular-focused healthcare accelerator that facilitates guaranteed hospital pilot projects and clinical trials for accomplished, early-stage companies bringing new cardiovascular innovations to the market.

Applications for the 2025 HeartX cohort opened on February 1st, and five companies will be selected in September 2025. The program is seeking companies in three categories: digital health and software, medical devices, and diagnostic platforms. Each company will receive $150,000 of investment capital and is guaranteed at least one pilot project or clinical study with cardiology practices in Arkansas and around the country.

“The HeartX program exemplifies our commitment to bridging the gap between promising cardiovascular innovations and real-world clinical validation,” said Jeff Stinson, director of HealthTech Arkansas. “By guaranteeing early-stage companies direct access to leading cardiology practices for pilots and clinical trials, we’re enabling these innovators to rapidly demonstrate impact, refine their solutions, and ultimately improve patient outcomes. We’re proud to collaborate with MedAxiom again to bring transformative technologies to market.”

“The HeartX accelerator provides young companies with what they need most – access,” said Joe Sasson, PhD, MedAxiom’s chief commercial officer and executive vice president of Ventures. “Participating in HeartX provides funding, exposure, and commercialization support, helping to reach dozens of cardiovascular programs looking for solutions to improve care delivery. We’re confident that this year’s applicants will consist of the best cardiovascular innovations globally, and we encourage all companies focused on improving cardiovascular care to apply.”

HealthTech Arkansas is in its eighth year of administering accelerator programs focused exclusively on provider engagement with early-stage companies, and is now in its fourth year of partnering with MedAxiom on HeartX.

More information can be found at HeartXaccelerator.com.

ABOUT HEALTHTECH ARKANSAS
HealthTech Arkansas helps to drive innovation for healthcare provider organizations through its accelerator programs and through internal innovation programming. Its flagship accelerator, HeartX, recruits worldwide for the most accomplished cardiovascular-focused startups in the areas of digital health, medical devices, and diagnostic platforms. Those companies accepted into the program are guaranteed at least one pilot project or clinical trial from among the ten largest hospitals and health systems in Arkansas. More information can be found at HealthTechArkansas.com.

ABOUT MEDAXIOM
MedAxiom, an American College of Cardiology Company, is the cardiovascular community’s premier source for organizational performance solutions. MedAxiom is transforming cardiovascular care by combining the knowledge and power of hundreds of cardiovascular organization members, thousands of administrators, clinicians and revenue cycle experts, and dozens of industry partners. Through the delivery of proprietary tools, smart data and proven strategies, MedAxiom helps cardiovascular organizations achieve the Quadruple Aim of better outcomes, lower costs, improved patient experience and improved clinician experience. Learn more at medaxiom.com.

For more information, contact:
Jeff Stinson
501.766.0633
389556@email4pr.com    

View original content to download multimedia:https://www.prnewswire.com/news-releases/heartx-cardiovascular-accelerator-seeks-innovative-early-stage-companies-for-2025-program-302365328.html

SOURCE HealthTech Arkansas